Concanamycin B, a vacuolar H+-ATPase specific inhibitor suppresses bone resorption in vitro

13Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

Effects of concanamycin B, a specific inhibitor of the vacuolar type H+- ATPase (V-ATPase), on the stimulation of hone resorption induced by parathyroid hormone (PTH) were examined in vitro. Concanamycin B was found to inhibit PTH-stimulated osteoclastic pit formation and to suppress the acidification of vacuolar organelles by V-ATPase in the osteoclasts. PTH- stimulated 45Ca release from prelabelled chick embryonic calvariae was also inhibited by concanamycin B in a dose-dependent manner. These results suggest that osteoclastic acidification of lacunae by V-ATPase plays an essential role in mineral dissolution and degradation of the organic matrix during bone resorption.

Cite

CITATION STYLE

APA

Woo, J. T., Ohba, Y., Tagami, K., Sumitani, K., Yamaguchi, K., & Tsuji, T. (1996). Concanamycin B, a vacuolar H+-ATPase specific inhibitor suppresses bone resorption in vitro. Biological and Pharmaceutical Bulletin, 19(2), 297–299. https://doi.org/10.1248/bpb.19.297

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free